Utah Pilots AI System for Prescription Refills
Utah has launched a pilot program for a state-approved AI system designed to handle prescription refills, part of a broader trend of states increasing their oversight of AI in healthcare. The initiative is testing the use of artificial intelligence in care processes, which may lead to new compliance and ethical standards for telehealth providers.
- The yearlong pilot program, which began in December 2025, is a partnership between Utah's Office of Artificial Intelligence Policy and the health-tech platform Doctronic. - Patients using the system must be in Utah, verify their identity with a photo ID and selfie, and pay a $4 fee for each renewal. - The program is limited to 30, 60, or 90-day refills for a pre-approved list of 192 medications for chronic conditions; it excludes controlled substances, painkillers, and ADHD medications. - If the AI detects any potential risks, such as new symptoms or possible side effects, the case is escalated to a Utah-licensed physician for a video consultation. - The pilot has a phased rollout: a physician must review the first 250 AI-approved renewals for each drug class before the system can operate autonomously for that medication. - This initiative is part of a larger trend, with 46 states introducing over 250 bills in 2025 to regulate AI in healthcare, focusing on areas like transparency and preventing automated insurance denials. - Utah's program operates within a "regulatory sandbox" created by the state's Artificial Intelligence Policy Act, which allows for the temporary waiver of some telehealth and licensing rules for testing new AI technologies under state oversight. - Pharmacists will be notified when a prescription is renewed by the AI and retain the authority to escalate any renewal to a human physician.
